ANDROGEN-INSENSITIVE PROSTATIC CANCER

Clinical trials for ANDROGEN-INSENSITIVE PROSTATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new ANDROGEN-INSENSITIVE PROSTATIC CANCER trials appear

Sign up with your email to follow new studies for ANDROGEN-INSENSITIVE PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental cancer drug trial halted early

Disease control Terminated

This study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that had stopped responding to hormone therapy, as well as other solid tumors. The trial aimed to see if the drug could slow cancer growth and shrink tumors. The study …

Matched conditions: ANDROGEN-INSENSITIVE PROSTATIC CANCER

Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

ANDROGEN-INSENSITIVE PROSTATIC CANCER

Get alerted when new ANDROGEN-INSENSITIVE PROSTATIC CANCER trials appear

Experimental cancer drug trial halted early